A series of novel substituted quinazolin-4(3H)-one derivatives were synthesized and screened in vivo for their antihypertensive activities. Out of eighteen synthesized compounds, seven i.e. 2a, 2c, 4a, 4d, 5d, 6a & 6b compounds have shown hypotensive effect and produced bradycardia. These compounds have shown better activity than reference drug Prazosin (which acts as anti-hypertensive agent by α1 blocking action). All the compounds have shown ALD50>1000mg/kg with maximum in 2c & 4d (>1200mg/kg).

No abstract

For Abstract see ChemInform Abstract in Full Text.

VIIIc) exhibit good hypotensive and bradycardiac responses. Some of them display even better efficacy than the reference drug clonidine. -(MALHOTRA, V.; PATHAK*, S. R.; NATH, R.; MUKHERJEE, D.; SHANKER, K.; Bioorg. Med. Chem. Lett. 21 (2011) 3, 936-939, http://dx.

No abstract